R
Raul D. Santos
Researcher at University of São Paulo
Publications - 463
Citations - 21660
Raul D. Santos is an academic researcher from University of São Paulo. The author has contributed to research in topics: Familial hypercholesterolemia & Medicine. The author has an hindex of 56, co-authored 404 publications receiving 16997 citations. Previous affiliations of Raul D. Santos include Albert Einstein Hospital.
Papers
More filters
Journal ArticleDOI
Effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease
Andrei C. Sposito,Raul C. Maranhão,Carmen G. C. Vinagre,Raul D. Santos,José Antonio Franchini Ramires +4 more
TL;DR: A potent effect of etofibrate on both chylomicron lipolysis and remnant removal was achieved, indicating that this drug can be used to improve this metabolism in future prospective studies.
Journal ArticleDOI
Familial hypercholesterolemia prevalence in an admixed racial society: Sex and race matter. The ELSA-Brasil.
TL;DR: FH affects 1 in 263 in ELSA-Brasil and affects disproportionally more Brown, and Black, than White (1 in 156), than White(1 in 417).
Journal ArticleDOI
Transfer of lipids to high-density lipoprotein (HDL) is altered in patients with familial hypercholesterolemia.
L. Martinez,Raul D. Santos,Marcio H. Miname,Débora F. Deus,Emerson Silva Lima,Raul C. Maranhão +5 more
TL;DR: The entry of UC into HDL for subsequent esterification is an important driving force for RCT and reduction of UC transfer to HDL was previously associated to precocious coronary heart disease.
Journal ArticleDOI
Algorithm for the treatment of type 2 diabetes: a position statement of Brazilian Diabetes Society
A. C. Lerario,Antonio Roberto Chacra,Augusto Pimazoni-Netto,Domingos A. Malerbi,Jorge Luiz Gross,José Ep de Oliveira,Marília B. Gomes,Raul D. Santos,Reine M C Fonseca,Roberto T. B. Betti,Roberto Raduan +10 more
TL;DR: A new Brazilian algorithm for the treatment of type 2 diabetes is proposed, based on the opinions of endocrinologists surveyed from a poll conducted on the Brazilian Diabetes Society website regarding the latest algorithm proposed by American Diabetes Association /European Association for the Study of Diabetes, published in January 2009.
Journal ArticleDOI
Case report: The efficacy and safety of lomitapide in a homozygous familial hypercholesterolemic child.
TL;DR: The efficiency and safety of a 49-month compassionate use of the microsomal transfer protein inhibitor lomitapide in a child with homozygous familial hypercholesterolemia is reported for the first time.